Ackerman Joelinsider trades

In SEC Form 4 filings, Ackerman Joel is listed as Director of Champions Oncology, Inc. (CSBR). Ackerman Joel reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.

Companies and roles

Company	Role	Transactions	Last filed
CSBRChampions Oncology, Inc.	Director	2	Oct 16

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-16

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CSBRChampions Oncology, Inc.	Oct 15	Oct 16	M	69,794	$1.60	$111,670	1,126,333	No	Form 4
CSBRChampions Oncology, Inc.	Oct 15	Oct 16	M · derivative	69,794	$1.60	$111,670	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.